The Column Group

The Column Group is a venture capital firm that focuses on building early-stage drug discovery companies based on unique scientific platforms and potential breakthrough therapeutics. Their strategy emphasizes long-term value generation by building fundamentally strong, science-driven companies from the ground up, primarily in the life sciences, including pharmaceuticals, biotechnology, and bioinformatics.